News
Cover Media US on MSN1d
Low Doses of CBD Could Harm Liver, New FDA Study ShowsA new clinical trial raises concerns about the safety of low doses of cannabidiol (CBD), even as CBD products continue to ...
Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels.
Around 5% of healthy adults exposed to cannabidiol show elevated liver enzyme levels exceeding the normal threshold alongside ...
A mom who almost lost her job for failing a drug test after taking "THC free" CBD gummies is campaigning for mandatory ...
The global cannabidiol market size was US$ 5.1 billion in 2021. The global cannabidiol market is expected to grow to US$ 18.1 billion by 2030 by registering a compound annual growth rate (CAGR) of ...
Cannabidiol, a naturally occurring chemical found in marijuana plants, is “not likely to be abused or create dependence,” an initial review by the WHO’s Expert Committee on Drug Dependence ...
Cannabidiol is one of more than 100 chemicals called cannabinoids that can be distilled from Cannabis plants, which include both marijuana and hemp.
Study: Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials.Image Credit: Creativan / Shutterstock. An ...
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet , 2018; DOI: 10.1016/S0140-6736 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results